These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7574507)

  • 21. Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals.
    Mottram JC; Coombs GH
    Exp Parasitol; 1985 Apr; 59(2):151-60. PubMed ID: 2982638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb(III)-sensitive and -resistant parasites.
    Lizarazo-Jaimes EH; Reis PG; Bezerra FM; Rodrigues BL; Monte-Neto RL; Melo MN; Frézard F; Demicheli C
    J Inorg Biochem; 2014 Mar; 132():30-6. PubMed ID: 24412095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.
    Bhattacharjee A; Majumder S; Majumdar SB; Choudhuri SK; Roy S; Majumdar S
    Int J Antimicrob Agents; 2015 Mar; 45(3):268-77. PubMed ID: 25600891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani.
    Shaked-Mishan P; Ulrich N; Ephros M; Zilberstein D
    J Biol Chem; 2001 Feb; 276(6):3971-6. PubMed ID: 11110784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.
    Neal RA; Croft SL
    J Antimicrob Chemother; 1984 Nov; 14(5):463-75. PubMed ID: 6096347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
    Dzamitika SA; Falcão CA; de Oliveira FB; Marbeuf C; Garnier-Suillerot A; Demicheli C; Rossi-Bergmann B; Frézard F
    Chem Biol Interact; 2006 Apr; 160(3):217-24. PubMed ID: 16524568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
    Sereno D; Holzmuller P; Lemesre JL
    Acta Trop; 2000 Jan; 74(1):25-31. PubMed ID: 10643904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
    Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate.
    Berman JD; Waddell D; Hanson BD
    Antimicrob Agents Chemother; 1985 Jun; 27(6):916-20. PubMed ID: 2411217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimony oxidation states in antileishmanial drugs.
    Franco MA; Barbosa AC; Rath S; Dorea JG
    Am J Trop Med Hyg; 1995 May; 52(5):435-7. PubMed ID: 7771610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy.
    Roberts WL; Rainey PM
    Anal Biochem; 1993 May; 211(1):1-6. PubMed ID: 8323020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro.
    Berman JD; Chulay JD; Hendricks LD; Oster CN
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):459-65. PubMed ID: 7081539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs.
    Franco AM; Grafova I; Soares FV; Gentile G; Wyrepkowski CD; Bolson MA; Sargentini É; Carfagna C; Leskelä M; Grafov A
    Int J Nanomedicine; 2016; 11():6771-6780. PubMed ID: 28008252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?
    Yardley V; Ortuno N; Llanos-Cuentas A; Chappuis F; Doncker SD; Ramirez L; Croft S; Arevalo J; Adaui V; Bermudez H; Decuypere S; Dujardin JC
    J Infect Dis; 2006 Oct; 194(8):1168-75. PubMed ID: 16991093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam.
    Zhou Y; Messier N; Ouellette M; Rosen BP; Mukhopadhyay R
    J Biol Chem; 2004 Sep; 279(36):37445-51. PubMed ID: 15220340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.
    Andrade JM; Baba EH; Machado-de-Avila RA; Chavez-Olortegui C; Demicheli CP; Frézard F; Monte-Neto RL; Murta SM
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4482-9. PubMed ID: 27161624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate.
    El Fadili K; Imbeault M; Messier N; Roy G; Gourbal B; Bergeron M; Tremblay MJ; Légaré D; Ouellette M
    Antimicrob Agents Chemother; 2008 Feb; 52(2):526-33. PubMed ID: 18070969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.
    Haimeur A; Ouellette M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1689-94. PubMed ID: 9661005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes.
    El Fadili K; Messier N; Leprohon P; Roy G; Guimond C; Trudel N; Saravia NG; Papadopoulou B; Légaré D; Ouellette M
    Antimicrob Agents Chemother; 2005 May; 49(5):1988-93. PubMed ID: 15855523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABCI3 Is a New Mitochondrial ABC Transporter from Leishmania major Involved in Susceptibility to Antimonials and Infectivity.
    Arcari T; Manzano JI; Gamarro F
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.